{"protocolSection": {"identificationModule": {"nctId": "NCT01033773", "orgStudyIdInfo": {"id": "2007-268"}, "organization": {"fullName": "Medstar Health Research Institute", "class": "OTHER"}, "briefTitle": "Stop Emergency Room Visits for Hyperglycemia Project - District of Columbia (DC)", "officialTitle": "STEP-DC: Stop Emergency Room Visits for Uncontrolled Hyperglycemia Project in the District of Columbia", "acronym": "STEP-DC"}, "statusModule": {"statusVerifiedDate": "2020-09", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2007-09"}, "primaryCompletionDateStruct": {"date": "2008-11", "type": "ACTUAL"}, "completionDateStruct": {"date": "2009-01", "type": "ACTUAL"}, "studyFirstSubmitDate": "2009-12-14", "studyFirstSubmitQcDate": "2009-12-14", "studyFirstPostDateStruct": {"date": "2009-12-16", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2020-08-13", "resultsFirstSubmitQcDate": "2020-09-11", "resultsFirstPostDateStruct": {"date": "2020-10-05", "type": "ACTUAL"}, "lastUpdateSubmitDate": "2020-09-11", "lastUpdatePostDateStruct": {"date": "2020-10-05", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "PRINCIPAL_INVESTIGATOR", "investigatorFullName": "Michelle Magee", "investigatorTitle": "Director, MedStar Diabetes Institute", "investigatorAffiliation": "Medstar Health Research Institute"}, "leadSponsor": {"name": "Medstar Health Research Institute", "class": "OTHER"}}, "oversightModule": {"oversightHasDmc": false}, "descriptionModule": {"briefSummary": "To demonstrate that a focused Emergency Department (ED) intervention for uncontrolled hyperglycemia enables safe and effective glycemic management and reduces emergency room re-visits. We assessed hypoglycemia BG \\< 60mg/dL; change in mean blood glucose and A1C, and ED revisits for hyperglycemia.", "detailedDescription": "Patients with BG \\> 200mg/dL presenting to an urban tertiary care hospital ED were enrolled in a 4 week prospective intervention with historic self-controls. Subjects returned at 12-72 hours, 2 and 4 weeks. Diabetes medications (including sulfonylureas, metformin and/or insulin) were initiated and/or adjusted at each visit using the intervention algorithm per presenting blood glucose and prior diabetes medications. Survival skills self-management education and navigation to outpatient services were provided."}, "conditionsModule": {"conditions": ["Type 2 Diabetes Mellitus"], "keywords": ["Type 2 diabetes mellitus", "Uncontrolled hyperglycemia", "Emergency Department"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["NA"], "designInfo": {"allocation": "NA", "interventionModel": "SINGLE_GROUP", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "NONE"}}, "enrollmentInfo": {"count": 86, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "Diabetes education and medication management", "type": "OTHER", "description": "All enrolled patients received the intervention. There was no comparative arm. The analysis was done as pre and post.", "interventionNames": ["Drug: Antihyperglycemic medication guideline for management of uncontrolled hyperglycemia presenting to the ED using metformin, sulfonylurea and/or insulin", "Behavioral: Diabetes survival skills self-management education"]}], "interventions": [{"type": "DRUG", "name": "Antihyperglycemic medication guideline for management of uncontrolled hyperglycemia presenting to the ED using metformin, sulfonylurea and/or insulin", "description": "Diabetes medications (including sulfonylureas, metformin and/or insulin) were initiated and/or adjusted at each visit using the intervention algorithm per presenting blood glucose and prior diabetes medications.", "armGroupLabels": ["Diabetes education and medication management"]}, {"type": "BEHAVIORAL", "name": "Diabetes survival skills self-management education", "description": "Survival skills DSME based upon current JCAHO and ADA joint recommendations for persons with diabetes prior to discharge to the outpatient setting was initiated in the ED and continued at the follow-up encounters.", "armGroupLabels": ["Diabetes education and medication management"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Total Number of Hypoglycemia Events (Blood Glucose < 60mg/dL) Within 24 Hours of Baseline Visit", "description": "Total Number of hypoglycemic events defined as Blood Glucose \\< 60 within 24 hours of index emergency room visit (baseline)", "timeFrame": "24 hours"}], "secondaryOutcomes": [{"measure": "Change in Mean Blood Glucose From Time of Presentation to Emergency Room to End of Intervention 30 Days From Baseline", "description": "Mean difference in of blood glucose in mg/dl between baseline mean BG and end of intervention mean BG 30 days from baseline", "timeFrame": "30 days"}, {"measure": "Change in Hemoglobin A1C From Baseline to End of Intervention at 30 Days", "description": "difference between mean hemoglobin A1C at baseline and mean Hemoglobin A1C to end of intervention", "timeFrame": "30 days"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* Age \\> 18 years\n* Type 2 Diabetes Mellitus,\n* random BG \\> 200 mg/dL,\n* willing and able to provide informed consent and to participate in diabetes self-management education (DSME)\n* stable for discharge from the ED once hyperglycemia treatment initiated.\n\nExclusion Criteria:\n\n* type 1 Diabetes Mellitus,\n* diabetic ketoacidosis or hyperosmolar non-ketotic state,\n* concomitant treatment with glucocorticoids (other than stable maintenance dose therapy),\n* cognitive or physical impairment preventing participation in DSME\n* unwillingness or inability to provide consent and/or attend follow-up visits.", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "18 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Michelle F Magee, MD, MBBCh", "affiliation": "Medstar Diabetes and Research Institutes, Georgetown University School of Medicine.", "role": "PRINCIPAL_INVESTIGATOR"}], "locations": [{"facility": "Washington Hospital Center", "city": "Washington", "state": "District of Columbia", "zip": "20010", "country": "United States", "geoPoint": {"lat": 38.89511, "lon": -77.03637}}]}}, "resultsSection": {"participantFlowModule": {"groups": [{"id": "FG000", "title": "Diabetes Education and Medication Management", "description": "All enrolled patients received the intervention. There was no comparative arm. The analysis was done as pre and post.\n\nAntihyperglycemic medication guideline for management of uncontrolled hyperglycemia presenting to the ED using metformin, sulfonylurea and/or insulin: Diabetes medications (including sulfonylureas, metformin and/or insulin) were initiated and/or adjusted at each visit using the intervention algorithm per presenting blood glucose and prior diabetes medications.\n\nDiabetes survival skills self-management education: Survival skills DSME based upon current JCAHO and ADA joint recommendations for persons with diabetes prior to discharge to the outpatient setting was initiated in the ED and continued at the follow-up encounters."}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "86"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "51"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "35"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "Intervention", "description": "All enrolled patients received the intervention. There was no comparative arm. The analysis was done as pre and post.\n\nAntihyperglycemic medication guideline for management of uncontrolled hyperglycemia presenting to the ED using metformin, sulfonylurea and/or insulin: Diabetes medications (including sulfonylureas, metformin and/or insulin) were initiated and/or adjusted at each visit using the intervention algorithm per presenting blood glucose and prior diabetes medications.\n\nDiabetes survival skills self-management education: Survival skills DSME based upon current JCAHO and ADA joint recommendations for persons with diabetes prior to discharge to the outpatient setting was initiated in the ED and continued at the follow-up encounters."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "86"}]}], "measures": [{"title": "Age, Customized", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Age 18-44", "measurements": [{"groupId": "BG000", "value": "28"}]}, {"title": "Age 45-64", "measurements": [{"groupId": "BG000", "value": "51"}]}, {"title": "Age 65 and older", "measurements": [{"groupId": "BG000", "value": "7"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "42"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "44"}]}]}]}, {"title": "Race (NIH/OMB)", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "American Indian or Alaska Native", "measurements": [{"groupId": "BG000", "value": "0"}]}, {"title": "Asian", "measurements": [{"groupId": "BG000", "value": "0"}]}, {"title": "Native Hawaiian or Other Pacific Islander", "measurements": [{"groupId": "BG000", "value": "0"}]}, {"title": "Black or African American", "measurements": [{"groupId": "BG000", "value": "76"}]}, {"title": "White", "measurements": [{"groupId": "BG000", "value": "4"}]}, {"title": "More than one race", "measurements": [{"groupId": "BG000", "value": "0"}]}, {"title": "Unknown or Not Reported", "measurements": [{"groupId": "BG000", "value": "6"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Total Number of Hypoglycemia Events (Blood Glucose < 60mg/dL) Within 24 Hours of Baseline Visit", "description": "Total Number of hypoglycemic events defined as Blood Glucose \\< 60 within 24 hours of index emergency room visit (baseline)", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "events", "timeFrame": "24 hours", "groups": [{"id": "OG000", "title": "Intervention", "description": "All enrolled patients received the intervention. There was no comparative arm. The analysis was done as pre and post.\n\nAntihyperglycemic medication guideline for management of uncontrolled hyperglycemia presenting to the ED using metformin, sulfonylurea and/or insulin: Diabetes medications (including sulfonylureas, metformin and/or insulin) were initiated and/or adjusted at each visit using the intervention algorithm per presenting blood glucose and prior diabetes medications.\n\nDiabetes survival skills self-management education: Survival skills DSME based upon current JCAHO and ADA joint recommendations for persons with diabetes prior to discharge to the outpatient setting was initiated in the ED and continued at the follow-up encounters."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "86"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0"}]}]}]}, {"type": "SECONDARY", "title": "Change in Mean Blood Glucose From Time of Presentation to Emergency Room to End of Intervention 30 Days From Baseline", "description": "Mean difference in of blood glucose in mg/dl between baseline mean BG and end of intervention mean BG 30 days from baseline", "populationDescription": "This data was only available for 51 patients therefore only 51 patients' results were analyzed.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mg/dl", "timeFrame": "30 days", "groups": [{"id": "OG000", "title": "Intervention", "description": "All enrolled patients received the intervention. There was no comparative arm. The analysis was done as pre and post.\n\nAntihyperglycemic medication guideline for management of uncontrolled hyperglycemia presenting to the ED using metformin, sulfonylurea and/or insulin: Diabetes medications (including sulfonylureas, metformin and/or insulin) were initiated and/or adjusted at each visit using the intervention algorithm per presenting blood glucose and prior diabetes medications.\n\nDiabetes survival skills self-management education: Survival skills DSME based upon current JCAHO and ADA joint recommendations for persons with diabetes prior to discharge to the outpatient setting was initiated in the ED and continued at the follow-up encounters."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "51"}]}], "classes": [{"title": "Mean BG at baseline", "categories": [{"measurements": [{"groupId": "OG000", "value": "356", "spread": "110"}]}]}, {"title": "Mean BG at end of intervention", "categories": [{"measurements": [{"groupId": "OG000", "value": "183", "spread": "103"}]}]}]}, {"type": "SECONDARY", "title": "Change in Hemoglobin A1C From Baseline to End of Intervention at 30 Days", "description": "difference between mean hemoglobin A1C at baseline and mean Hemoglobin A1C to end of intervention", "populationDescription": "Only 46 patients had a baseline and end of intervention A1C available therefore only 46 participants are included in the data", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "percentage of hemoglobin A1C", "timeFrame": "30 days", "groups": [{"id": "OG000", "title": "Intervention", "description": "All enrolled patients received the intervention. There was no comparative arm. The analysis was done as pre and post.\n\nAntihyperglycemic medication guideline for management of uncontrolled hyperglycemia presenting to the ED using metformin, sulfonylurea and/or insulin: Diabetes medications (including sulfonylureas, metformin and/or insulin) were initiated and/or adjusted at each visit using the intervention algorithm per presenting blood glucose and prior diabetes medications.\n\nDiabetes survival skills self-management education: Survival skills DSME based upon current JCAHO and ADA joint recommendations for persons with diabetes prior to discharge to the outpatient setting was initiated in the ED and continued at the follow-up encounters."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "46"}]}], "classes": [{"title": "Mean baseline A1C", "categories": [{"measurements": [{"groupId": "OG000", "value": "12.0", "spread": "1.5"}]}]}, {"title": "Mean end of intervention A1C", "categories": [{"measurements": [{"groupId": "OG000", "value": "11.6", "spread": "1.6"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "0", "eventGroups": [{"id": "EG000", "title": "Intervention", "description": "All enrolled patients received the intervention. There was no comparative arm. The analysis was done as pre and post.\n\nAntihyperglycemic medication guideline for management of uncontrolled hyperglycemia presenting to the ED using metformin, sulfonylurea and/or insulin: Diabetes medications (including sulfonylureas, metformin and/or insulin) were initiated and/or adjusted at each visit using the intervention algorithm per presenting blood glucose and prior diabetes medications.\n\nDiabetes survival skills self-management education: Survival skills DSME based upon current JCAHO and ADA joint recommendations for persons with diabetes prior to discharge to the outpatient setting was initiated in the ED and continued at the follow-up encounters.", "deathsNumAffected": 0, "deathsNumAtRisk": 86, "seriousNumAffected": 0, "seriousNumAtRisk": 86, "otherNumAffected": 14, "otherNumAtRisk": 86}], "otherEvents": [{"term": "Hypoglycemia", "organSystem": "Endocrine disorders", "notes": "Blood sugar less then 70 mg/dl", "stats": [{"groupId": "EG000", "numEvents": 26, "numAffected": 14, "numAtRisk": 86}]}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": true}, "pointOfContact": {"title": "Dr Michelle Magee", "organization": "MedStar Health Research Institute", "email": "michelle.f.magee@medstar.net", "phone": "2028772383"}}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000003920", "term": "Diabetes Mellitus"}, {"id": "D000003924", "term": "Diabetes Mellitus, Type 2"}, {"id": "D000006943", "term": "Hyperglycemia"}, {"id": "D000004630", "term": "Emergencies"}], "ancestors": [{"id": "D000044882", "term": "Glucose Metabolism Disorders"}, {"id": "D000008659", "term": "Metabolic Diseases"}, {"id": "D000004700", "term": "Endocrine System Diseases"}, {"id": "D000020969", "term": "Disease Attributes"}, {"id": "D000010335", "term": "Pathologic Processes"}], "browseLeaves": [{"id": "M7115", "name": "Diabetes Mellitus", "asFound": "Diabetes Mellitus", "relevance": "HIGH"}, {"id": "M7119", "name": "Diabetes Mellitus, Type 2", "asFound": "Type 2 Diabetes Mellitus", "relevance": "HIGH"}, {"id": "M7796", "name": "Emergencies", "asFound": "Emergency", "relevance": "HIGH"}, {"id": "M9994", "name": "Hyperglycemia", "asFound": "Hyperglycemia", "relevance": "HIGH"}, {"id": "M11639", "name": "Metabolic Diseases", "relevance": "LOW"}, {"id": "M25403", "name": "Glucose Metabolism Disorders", "relevance": "LOW"}, {"id": "M7862", "name": "Endocrine System Diseases", "relevance": "LOW"}, {"id": "M22700", "name": "Disease Attributes", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC18", "name": "Nutritional and Metabolic Diseases"}, {"abbrev": "BC19", "name": "Gland and Hormone Related Diseases"}, {"abbrev": "All", "name": "All Conditions"}, {"abbrev": "BC23", "name": "Symptoms and General Pathology"}]}, "interventionBrowseModule": {"meshes": [{"id": "D000008687", "term": "Metformin"}, {"id": "D000007004", "term": "Hypoglycemic Agents"}], "ancestors": [{"id": "D000045505", "term": "Physiological Effects of Drugs"}], "browseLeaves": [{"id": "M10365", "name": "Insulin", "relevance": "LOW"}, {"id": "M11667", "name": "Metformin", "asFound": "Assessment", "relevance": "HIGH"}, {"id": "M173166", "name": "Insulin, Globin Zinc", "relevance": "LOW"}, {"id": "M10054", "name": "Hypoglycemic Agents", "asFound": "Severity score", "relevance": "HIGH"}], "browseBranches": [{"abbrev": "Hypo", "name": "Hypoglycemic Agents"}, {"abbrev": "All", "name": "All Drugs and Chemicals"}]}}, "hasResults": true}